Is Taking Wegovy Safe? Honest Answers on Risk, Side Effects and When to Ask for Help

You've just been prescribed Wegovy and you're wondering what you're letting yourself in for

That worry is one our prescribers hear most weeks. People have usually done a lot of reading before they start, and they arrive at the consultation with a mix of cautious optimism and genuine anxiety about what the injections might do to their body. That is a reasonable place to be, and it deserves a straight answer rather than a pamphlet.

Wegovy has a well-characterised safety profile built from large, long-term clinical trials, and if you want a thorough grounding in whether Wegovy is safe before your first injection, that dedicated page covers the evidence in full. The STEP 1 trial, published in the New England Journal of Medicine, followed participants across 68 weeks and found that gastrointestinal symptoms were the most frequently reported issue by a significant margin. Around three-quarters of participants on semaglutide reported at least one GI event; for most, these were mild to moderate and resolved with time. Nausea tends to be the most noticeable, particularly after starting or moving up a dose. Loose stools, constipation and indigestion all appear on the list too. A smaller group experiences what patients sometimes describe as sulphur burps, which, while not dangerous, can be uncomfortable enough to worry people; the reasons behind that particular side effect are worth understanding before treatment begins.

These effects tend to peak in the first day or two after each injection, then ease. Eating smaller meals, chewing slowly and avoiding rich or fatty food around injection day makes a practical difference for most people. None of this is a reason to stop on your own without speaking to a prescriber first.

Serious but rare: the risks that need your attention, not your panic

Safety means being honest about the rarer end of the risk spectrum, not just the common side effects. The MHRA's Drug Safety Update of January 2026 highlighted acute pancreatitis as an infrequent but potentially serious adverse event associated with GLP-1 receptor agonists, including semaglutide. The key symptom to recognise is severe, persistent stomach pain, pain that does not ease and may radiate through to your back, with or without vomiting. That warrants urgent medical attention, not a wait-and-see approach.

Gallbladder problems, including gallstones, are also flagged in the prescribing information. Rapid weight loss of any kind can increase gallstone risk, and Wegovy is no exception. Symptoms worth acting on include pain in the upper right abdomen, fever or yellowing of the skin or eyes.

Other symptoms that should prompt a call or visit to a healthcare professional include signs of dehydration following severe vomiting or diarrhoea (dark urine, dizziness, very little output), any allergic reaction such as swelling of the face or throat, and (for anyone also managing diabetes) unusual changes in vision, which can occasionally reflect rapid glycaemic shifts. If you have concerns about your current treatment, our clinical team are reachable through our support line, seven days a week.

The full list of contraindications and warnings (including people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome) is set out in the Wegovy Patient Information Leaflet and the Mounjaro and Wegovy SmPCs on the electronic Medicines Compendium. Your prescriber works through these before approving treatment; they are not small print to skip.

What makes Wegovy safer: the role of clinical oversight and genuine supply

The medicine's safety profile does not exist in isolation from how it is prescribed. Counterfeit semaglutide pens, sold through social media and unofficial channels, have been seized in the UK in large numbers by the MHRA. Some have contained insulin rather than semaglutide. The risk of an unregulated product goes far beyond a different side-effect list. Legitimate Wegovy can only be obtained through a prescription, following clinical assessment from a qualified prescriber.

At nume, a GPhC-registered Independent Prescriber personally reviews every consultation (not a scoring algorithm) the same day it is submitted. That review covers your medical history, current medicines, contraindications and the clinical suitability of the dose. Wegovy does interact with some medicines, and the oral contraceptive pill absorbs less reliably when gastric emptying slows; anyone on the pill should discuss whether an additional method is needed during treatment. A full overview of what Wegovy involves, including eligibility, is on our Wegovy treatment page.

Worth knowing too: every repeat supply at nume is reviewed clinically before dispatch. If you are responding well and tolerating treatment, that is confirmed. If something has changed, it is caught. That is what the GPhC registration framework requires, and what a clinician-led service should do in practice.

When to stop, when to push through and how our prescribers handle the grey areas

One of the harder questions is when a side effect is a reason to pause or stop, and when it is a short-term adjustment worth riding out. The side-effect detail page goes into more granular territory; the general principle is that transient nausea in the first week of a new dose is expected, whereas worsening symptoms that do not settle, or any of the serious signs listed above, are not.

Stopping Wegovy abruptly raises a separate question about what happens to weight and appetite afterward. That is something people understandably think through before they start. It is worth asking at consultation stage rather than discovering it mid-treatment.

If you have questions about whether Wegovy is appropriate given your own health background, cost and how the private prescription route works is outlined on the Wegovy price page, and our prescribers discuss suitability and side effects as part of every free consultation. You can start your free consultation here, and the whole picture (clinical review, what you'll be asked, what happens next) is explained before you make any commitment.